株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ジェネリック注射剤の世界市場:産業動向、シェア、市場規模、成長率、市場機会、予測

Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 547086
出版日 ページ情報 英文 162 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
ジェネリック注射剤の世界市場:産業動向、シェア、市場規模、成長率、市場機会、予測 Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年06月10日 ページ情報: 英文 162 Pages
概要

当レポートでは、ジェネリック注射剤の世界市場について調査し、全体的な市場動向、治療分野・流通チャネル・地域別の詳細動向、関連市場の概要、競合情勢、製造工程やプロジェクトの経済性などについて包括的にまとめています。

第1章 序文

第2章 調査範囲・調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場概要
  • 主な産業動向

第5章 ジェネリック医薬品の世界市場

  • 市場概要
  • 市場実績
  • 市場内訳:地域別
  • 市場予測
  • 主要企業

第6章 ジェネリックドラッグデリバリーの世界市場

  • 経口剤
  • 注射剤
  • 経皮投与剤
  • 吸入剤

第7章 ジェネリック注射剤の世界市場

  • 市場概要
  • 市場実績
  • 市場内訳:地域別
  • 市場内訳:治療分野別
  • 市場内訳:流通チャネル別
  • 市場予測
  • SWOT分析
  • バリューチェーン分析
  • ファイブフォース分析

第8章 ジェネリック注射剤の世界市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 市場分析:治療分野別

  • 麻酔
  • 抗感染症薬
  • 高カロリー輸液
  • 心血管

第10章 市場分析:流通チャネル別

  • 病院
  • 小売薬局

第11章 競合情勢

  • 競合構造
  • 主要企業

第12章 ジェネリック注射剤の製造工程

  • 製品概要
  • 詳細なプロセスフロー
  • 単位操作の種類
  • 物質収支・原材料の要件

第13章 プロジェクトの詳細・要件・経費

  • 土地
  • 建設
  • 工場
  • 機械
  • 原材料
  • 包装
  • 物流
  • ユーティリティ
  • 労働力
  • その他の資本設備

第14章 貸付金・資金援助

第15章 プロジェクトの経済性

  • プロジェクトの資本コスト
  • 技術・経済パラメーター
  • 製品価格
  • 税金・減価償却費
  • 収入予測
  • 支出予測
  • 財務分析
  • 収益分析
図表

List of Figures

  • Figure 1: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2011 - 2018
  • Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2018
  • Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2019 - 2024
  • Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2011, 2018 & 2024
  • Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2011, 2018 & 2024
  • Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2011, 2018 & 2024
  • Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2011, 2018 & 2024
  • Figure 8: Global: Generic Injectables Market: Sales Value Trends (in Billion US$), 2011 - 2018
  • Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2018
  • Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2018
  • Figure 11: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2018
  • Figure 12: Global: Generic Injectables Market Forecast: Sales Value Trends (in Billion US$), 2019 - 2024
  • Figure 13: Global: Generic Injectables Industry: SWOT Analysis
  • Figure 14: Global: Generic Injectables Industry: Value Chain Analysis
  • Figure 15: Global: Generic Injectables Industry: Porter's Five Forces Analysis
  • Figure 16: North America: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
  • Figure 17: Europe: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
  • Figure 18: Asia: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
  • Figure 19: Latin America: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
  • Figure 20: Middle East and Africa: Generic Injectable Market (in Billion US$), 2011, 2018 & 2024
  • Figure 21: Global: Generic Injectable (Oncology) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 22: Global: Generic Injectable (Oncology) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 23: Global: Generic Injectable (Anaesthesia) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 24: Global: Generic Injectable (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 25: Global: Generic Injectable (Anti-infectives) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 26: Global: Generic Injectable (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 27: Global: Generic Injectable (Parenteral Nutrition) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 28: Global: Generic Injectable (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 29: Global: Generic Injectable (Cardiovascular) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 30: Global: Generic Injectable (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 31: Global: Generic Injectable (Vials) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 32: Global: Generic Injectable (Vials) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 33: Global: Generic Injectable (Ampoules) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 34: Global: Generic Injectable (Ampoules) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 35: Global: Generic Injectable (Premix) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 36: Global: Generic Injectable (Premix) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 37: Global: Generic Injectable (Prefilled Syringes) Market: Value Trends (in Million US$), 2011 & 2018
  • Figure 38: Global: Generic Injectable (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2019-2024
  • Figure 39: US: Generic Injectable Market: Sales through Hospitals (in Million US$), 2011 & 2018
  • Figure 40: Global: Generic Injectable Market Forecast: Sales through Hospitals (in Million US$), 2019-2024
  • Figure 41: Global: Generic Injectable Market: Sales through Retail Pharmacy (in Million US$), 2011 & 2018
  • Figure 42: Global: Generic Injectable Market Forecast: Sales through Retail Pharmacy (in Million US$), 2019-2024
  • Figure 43: Generic Injectable Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 44: Generic Injectable Manufacturing: Detailed Process Flow
  • Figure 45: Generic Injectable Manufacturing: Production Cost Breakup (in %)
  • Figure 46: Generic Injectable Industry: Profit Margins at Various Levels of the Supply Chain
  • Figure 47: Generic Injectable Manufacturing Plant: Proposed Plant Layout
  • Figure 48: Generic Injectable Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

  • Table 1: Global: Generic Drug Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2019 - 2024
  • Table 3: Global: Generic Drug Market: Revenues of Key Players (in US$ Billion), 2018
  • Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
  • Table 5: Global: Generic Injectables Market Forecast: Breakup by Region, 2019 - 2024
  • Table 6: Generic Injectable Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 7: Generic Injectable Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 8: Generic Injectable Manufacturing Plant: Costs Related to Machinery Unit (in US$)
  • Table 9: Generic Injectable Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
  • Table 10: Generic Injectable Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 11: Generic Injectable Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
  • Table 12: Details of Financial Assistance Offered by Financial Institutions
  • Table 13: Generic Injectable Manufacturing Plant: Capital Costs (in US$)
  • Table 14: Generic Injectable Manufacturing Plant: Techno-Economic Parameters (in US$)
  • Table 15: Generic Injectable Manufacturing Plant: Taxation and Depreciation (in US$)
  • Table 16: Generic Injectable Manufacturing Plant: Income Projections (in US$)
  • Table 17: Generic Injectable Manufacturing Plant: Expenditure Projections (in US$)
  • Table 18: Generic Injectable Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
  • Table 19: Generic Injectable Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
  • Table 20: Generic Injectable Manufacturing Plant: Profit and Loss Account (in US$)
目次
Product Code: SR1019C72_Report

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

Owing to the advantages offered by generic injectables, governments in various countries are supporting their manufacture. Additionally, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population and rising prevalence of chronic as well as lifestyle diseases represent some of the other factors driving the growth of the market. According to IMARC Group's latest report titled, "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024", the global generic injectables market reached a value of US$ 28.6 Billion in 2018, exhibiting a CAGR of 9.3% during 2011-2018.

The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share. On a regional-basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the global market. The report has also analysed the competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter.

This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.

Key Questions Answered in This Report:

  • How has the generic injectables market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic injectables industry?
  • What are the price trends of generic injectables?
  • What are the various stages in the value chain of the generic injectables industry?
  • What are the key driving factors and challenges in the generic injectables industry?
  • What is the structure of the global generic injectables industry and who are the key players?
  • What is the degree of competition in the global generic injectables industry?
  • What are the profit margins in the generic injectables industry?
  • What are the key requirements for setting up a generic injectables manufacturing plant?
  • How are generic injectables manufactured?
  • What are the various unit operations involved in a generic injectables manufacturing plant?
  • What is the total size of land required for setting up a generic injectables manufacturing plant?
  • What are the machinery requirements for setting up a generic injectables manufacturing plant?
  • What are the raw material requirements for setting up a generic injectables manufacturing plant?
  • What are the packaging requirements for generic injectables?
  • What are the transportation requirements for generic injectables?
  • What are the utility requirements for setting up a generic injectables manufacturing plant?
  • What are the manpower requirements for setting up a generic injectables manufacturing plant?
  • What are the infrastructure costs for setting up a generic injectables manufacturing plant?
  • What are the capital costs for setting up a generic injectables manufacturing plant?
  • What are the operating costs for setting up a generic injectables manufacturing plant?
  • What will be the income and expenditures for a generic injectables manufacturing plant?
  • What is the time required to break-even?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Generic Drug Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Region
  • 5.4 Market Forecast
  • 5.5 Major Players

6 Global Generic Drug Delivery Market

  • 6.1 Oral
  • 6.2 Injectables
  • 6.3 Dermal/Topical
  • 6.4 Inhalers

7 Global Generic Injectables Market

  • 7.1 Market Overview
  • 7.2 Market Performance
  • 7.3 Market Breakup by Region
  • 7.4 Market Breakup by Therapeutic Area
  • 7.5 Market Breakup by Container
  • 7.6 Market Breakup by Distribution Channel
  • 7.7 Market Forecast
  • 7.8 SWOT Analysis
    • 7.8.1 Overview
    • 7.8.2 Strengths
    • 7.8.3 Weaknesses
    • 7.8.4 Opportunities
    • 7.8.5 Threats
  • 7.9 Value Chain Analysis
  • 7.10 Porter's Five Forces Analysis
    • 7.10.1 Overview
    • 7.10.2 Bargaining Power of Buyers
    • 7.10.3 Bargaining Power of Suppliers
    • 7.10.4 Degree of Competition
    • 7.10.5 Threat of New Entrants
    • 7.10.6 Threat of Substitutes
  • 7.11 Key Market Drivers and Success Factors

8 Global Generic Injectables Market: Performance of Key Regions

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market by Therapeutic Area

  • 9.1 Oncology
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Anaesthesia
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Anti-infectives
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Parenteral Nutrition
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Cardiovascular
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market by Container

  • 10.1 Vials
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ampoules
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Premix
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Prefilled Syringes
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market by Distribution Channel

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Retail Pharmacy
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast

12 Global Generic Injectable Market: Competitive Landscape

  • 12.1 Competitive Structure
  • 12.2 Market Breakup by Key Players

13 Generic Injectable Manufacturing Process

  • 13.1 Product Overview
  • 13.2 Detailed Process Flow (Injectable)
  • 13.3 Various Types of Unit Operations Involved
  • 13.4 Mass Balance and Raw Material Requirements

14 Project Details, Requirements and Costs Involved

  • 14.1 Land Requirements and Expenditures
  • 14.2 Construction Requirements and Expenditures
  • 14.3 Plant Machinery
  • 14.4 Machinery Pictures
  • 14.5 Raw Material Requirements and Expenditures
  • 14.6 Packaging Requirements and Expenditures
  • 14.7 Transportation Requirements and Expenditures
  • 14.8 Utility Requirements and Expenditures
  • 14.9 Manpower Requirements and Expenditures
  • 14.10 Other Capital Investments

15 Loans and Financial Assistance

16 Project Economics

  • 16.1 Capital Cost of the Project
  • 16.2 Techno-Economic Parameters
  • 16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
  • 16.4 Taxation and Depreciation
  • 16.5 Income Projections
  • 16.6 Expenditure Projections
  • 16.7 Financial Analysis
  • 16.8 Profit Analysis

17 Key Player Profiles

  • 17.1 Hospira (Pfizer)
    • 17.1.1 Company Overview
    • 17.1.2 Product Portfolio
    • 17.1.3 Financials
    • 17.1.4 SWOT Analysis
  • 17.2 Fresenius Kabi
    • 17.2.1 Company Overview
    • 17.2.2 Product Portfolio
    • 17.2.3 Financials
    • 17.2.4 SWOT Analysis
  • 17.3 Hikma
    • 17.3.1 Company Overview
    • 17.3.2 Product Portfolio
    • 17.3.3 Financials
    • 17.3.4 SWOT Analysis
  • 17.4 Sandoz (Novartis)
    • 17.4.1 Company Overview
    • 17.4.2 Product Portfolio
    • 17.4.3 Financials
    • 17.4.4 SWOT Analysis
  • 17.5 Sagent
    • 17.5.1 Company Overview
    • 17.5.2 Product Portfolio
    • 17.5.3 Financials
    • 17.5.4 SWOT Analysis
  • 17.6 Sanofi
    • 17.6.1 Company Overview
    • 17.6.2 Product Portfolio
    • 17.6.3 Financials
    • 17.6.4 SWOT Analysis
  • 17.7 Baxter
    • 17.7.1 Company Overview
    • 17.7.2 Product Portfolio
    • 17.7.3 Financials
    • 17.7.4 SWOT Analysis
Back to Top